Sophie is an administrator at CoSyne, responsible for supporting the senior leadership team and wider company. She holds a PhD in Neuroscience from the University of Otago, New Zealand, which assessed a novel gene therapy approach for treating Alzheimer’s disease. Prior to immigrating to the UK, she held positions as a Teaching Fellow in Psychology and in Business Support for a New Zealand neuroscience initiative. Sophie is driven by her long-standing passion for the treatment of neurological diseases, and the loss of her dad to brain cancer in 2019.